{"Carbimazole":{"RelatedTo":"Thyroid peroxidase","Synonym":["Athyromazole","Carbethoxymethimazole","Carbimazol","Carbimazol (INN-Spanish","French)","Carbimazolum (INN-Latin)","Carbinazole","Atirozidina","Basolest","CG1","Carbimazol Spofa","Carbotiroid","Mertiran","Neo-Mercazole","Neo-Thyreostat","Neo-Tireol","Neomercazole"],"SuperCategory":"Molecular entity","Comment":"taken from DrugBank","Id":"DB00389","Curator":"ab","Has role":"Drug","DefiningCitation":"http:\/\/www.drugbank.ca\/drugs\/DB00389","Definition":"An imidazole antithyroid agent. Carbimazole is metabolized to methimazole, which is responsible for the antithyroid activity. (PubChem) Pharmacology: Carbimazole is a carbethoxy derivative of methimazole. Its antithyroid action is due to its conversion to methimazole after absorption. It is used to treat hyperthyroidism and thyrotoxicosis. Mechanism of action: Carbimazole is an aitithyroid agent that decreases the uptake and concentration of inorganic iodine by thyroid, it also reduces the formation of di-iodotyrosine and thyroxine. Drug type: Approved. Small Molecule. Drug category: Antithyroid Agents"}}